ArticleJournal of lipid research2015

Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9.

Sam J L van der Tuin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.